Market Research Logo

Pharmacovigilance and Drug Safety Software Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

Pharmacovigilance and Drug Safety Software Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

The report on global pharmacovigilance and drug safety software market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global pharmacovigilance and drug safety software market to grow with a CAGR of 5.3% over the forecast period of 2018-2024. The study on pharmacovigilance and drug safety software market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.
The various government associations such as European Medicines Evaluation Agency (EMEA) and the U.S. Food and Drug Administration (FDA) are have very strict rules and regulation regarding the drugs approval. The drug’s safety is the major concern for these organizations. The growing pressure from the government agencies to developed novel and safe drug is driving the growth of pharmacovigilance and drug safety software market across the world. In addition, growing occurrence of Rates of Adverse Drug Reactions (ADRs) are anticipated to boost the growth of pharmacovigilance and drug safety software market.
The adoption of Pharmacovigilance software are rising vary rapidly across numerous outsourcing firms to ensure the safe and effective manufacturing is likely to contribute in the growth of pharmacovigilance and drug safety software market. However, lack of skill workforce in the Pharmacovigilance is hampering the growth of pharmacovigilance and drug safety software market. Moreover, ongoing research and development activity to develop the effective software and growing awareness about the benefits of pharmacovigilance and drug safety soft wares are projected to create various growth opportunities in upcoming year.
Geographically, North America dominates the pharmacovigilance and drug safety software market. The growing adoption of pharmacovigilance and drug safety software, developed healthcare infrastructure and demand of new and safe drugs are the key factors driving the growth of pharmacovigilance and drug safety software market in North America. In addition, Asia Pacific is the fastest growing region in the pharmacovigilance and drug safety software market owing to the growing government investment in pharmaceutical secotor, rising demand of pharmacovigilance and drug safety softwares from the various hospitals and clinics and many others.
The report on pharmacovigilance and drug safety software market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global pharmacovigilance and drug safety software market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global pharmacovigilance and drug safety software market over the period of 2016 to 2024. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global pharmacovigilance and drug safety software market is segmented on the basis of software, mode of delivery and end-user.

Global Pharmacovigilance And Drug Safety Software Market by Software
Adverse Event Reporting Software
Issue Tracking Software
Fully Integrated Software
Drug Safety Audits Software
Global Pharmacovigilance And Drug Safety Software Market by Mode Of Delivery
On-premise
Cloud-based
Global Pharmacovigilance And Drug Safety Software Market by End-User
Pharma & Biotech Companies
Contract Research Organizations (CROs)
Pharmacovigilance Service Providers
Business Process Outsourcing (BPO) Firms

Company Profiles
UMBRA Global LLC
United BioSource Corporation
Oracle Corporation
Sparta Systems
AB Cube
Arisglobal
Extedo GMBH
Ennov
Online Business Applications
Sarjen Systems Pvt

How this report delivers?
1. Comprehensive analysis of global as well as regional markets of pharmacovigilance and drug safety software market.
2. Complete coverage of all the segments in pharmacovigilance and drug safety software market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in global pharmacovigilance and drug safety software market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


The report on pharmacovigilance and drug safety software market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global pharmacovigilance and drug safety software market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Pharmacovigilance and Drug safety software Market Highlights
2.2. Pharmacovigilance and Drug safety software Market Projection
2.3. Pharmacovigilance and Drug safety software Market Regional Highlights
3. Global Pharmacovigilance and Drug Safety Software Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Software
3.4.2. IGR-Growth Matrix Analysis by Mode Of Delivery
3.4.3. IGR-Growth Matrix Analysis by End-User
3.4.4. IGR-Growth Matrix Analysis by Region
3.5. Value chain Pharmacovigilance and Drug safety software Market
4. Pharmacovigilance and Drug Safety Software Market Macro Indicator Analysis
5. Global Pharmacovigilance and Drug Safety Software Market by Software
5.1. Adverse Event Reporting Software
5.2. Issue Tracking Software
5.3. Fully Integrated Software
5.4. Drug Safety Audits Software
6. Global Pharmacovigilance and Drug Safety Software Market by Mode Of Delivery
6.1. On-premise
6.2. Cloud-based
7. Global Pharmacovigilance and Drug Safety Software Market by End-User
7.1. Pharma & Biotech Companies
7.2. Contract Research Organizations (CROs)
7.3. Pharmacovigilance Service Providers
7.4. Business Process Outsourcing (BPO) Firms
8. Global Pharmacovigilance and Drug Safety Software Market by Region 2018-2024
8.1. North America
8.1.1. North America Pharmacovigilance and Drug Safety Software Market by Software
8.1.2. North America Pharmacovigilance and Drug Safety Software Market by Mode Of Delivery
8.1.3. North America Pharmacovigilance and Drug Safety Software Market by End-user
8.1.4. North America Pharmacovigilance and Drug Safety Software Market by Country
8.2. Europe
8.2.1. Europe Pharmacovigilance and Drug Safety Software Market by Software
8.2.2. Europe Pharmacovigilance and Drug Safety Software Market by Mode Of Delivery
8.2.3. Europe Pharmacovigilance and Drug Safety Software Market by End-user
8.2.4. Europe Pharmacovigilance and Drug Safety Software Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Pharmacovigilance and Drug Safety Software Market by Software
8.3.2. Asia-Pacific Pharmacovigilance and Drug Safety Software Market by Mode Of Delivery
8.3.3. Asia-Pacific Pharmacovigilance and Drug Safety Software Market by End-user
8.3.4. Asia-Pacific Pharmacovigilance and Drug Safety Software Market by Country
8.4. RoW
8.4.1. RoW Pharmacovigilance and Drug Safety Software Market by Software
8.4.2. RoW Pharmacovigilance and Drug Safety Software Market by Mode Of Delivery
8.4.3. RoW Pharmacovigilance and Drug Safety Software Market by End-user
8.4.4. RoW Pharmacovigilance and Drug Safety Software Market by Sub-region
9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Pharmacovigilance and Drug Safety Software Market
9.2. Companies Profiles
9.2.1. Umbra Global Llc
9.2.1.1. Overview
9.2.1.2. Company Snapshot
9.2.1.3. Financial Snapshot
9.2.1.4. Product portfolio
9.2.1.5. Recent developments
9.2.2. United Biosource Corporation
9.2.2.1. Overview
9.2.2.2. Company Snapshot
9.2.2.3. Financial Snapshot
9.2.2.4. Product portfolio
9.2.2.5. Recent developments
9.2.3. Oracle Corporation
9.2.3.1. Overview
9.2.3.2. Company Snapshot
9.2.3.3. Financial Snapshot
9.2.3.4. Product portfolio
9.2.3.5. Recent developments
9.2.4. Sparta Systems
9.2.4.1. Overview
9.2.4.2. Company Snapshot
9.2.4.3. Financial Snapshot
9.2.4.4. Product portfolio
9.2.4.5. Recent developments
9.2.5. Ab Cube
9.2.5.1. Overview
9.2.5.2. Company Snapshot
9.2.5.3. Financial Snapshot
9.2.5.4. Product portfolio
9.2.5.5. Recent developments
9.2.6. Arisglobal
9.2.6.1. Overview
9.2.6.2. Company Snapshot
9.2.6.3. Financial Snapshot
9.2.6.4. Product portfolio
9.2.6.5. Recent developments
9.2.7. Extedo Gmbh
9.2.7.1. Overview
9.2.7.2. Company Snapshot
9.2.7.3. Financial Snapshot
9.2.7.4. Product portfolio
9.2.7.5. Recent developments
9.2.8. Ennov
9.2.8.1. Overview
9.2.8.2. Company Snapshot
9.2.8.3. Financial Snapshot
9.2.8.4. Product portfolio
9.2.8.5. Recent developments
9.2.9. Online Business Applications
9.2.9.1. Overview
9.2.9.2. Company Snapshot
9.2.9.3. Financial Snapshot
9.2.9.4. Product portfolio
9.2.9.5. Recent developments
9.2.10. Sarjen Systems Pvt
9.2.10.1. Overview
9.2.10.2. Company Snapshot
9.2.10.3. Financial Snapshot
9.2.10.4. Product portfolio
9.2.10.5. Recent developments
10. Appendix
10.1. Primary research findings and questionnaire

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report